B35.5
Tinea imbricata
Clinical Classification Guidelines
Inclusion Terms
- Tokelau
Medical Intelligence & Overview
Tinea imbricata is a chronic fungal skin infection characterized by overlapping rings or patches with a scaly, inflamed border. This condition typically affects regions with warm, humid climates, notably in certain Pacific islands such as Tokelau. It is caused by a specific type of dermatophyte fungi and tends to recur if not properly managed. Recognizing the symptoms and understanding its causes can aid in early identification, although professional diagnosis and treatment are essential.
Causes & Symptoms
Clinical Causes: Infection with dermatophyte fungi, specifically Trichophyton concentricum Prolonged exposure to humid and sweaty environments Close contact with individuals who have the infection Shared clothing, towels, or bedding that may harbor fungal spores Poor personal hygiene
Key Symptoms: Multiple concentric rings or patches on the skin, often with a scaly or flaky texture Itching or discomfort around affected areas Inflammation or redness at the edges of the patches Hypopigmentation or hyperpigmentation within the lesions Recurrence of patches in the same area if untreated Commonly affects the trunk, limbs, and neck
Diagnostic & Treatment
Diagnosis Path: Diagnosis of tinea imbricata primarily involves a physical examination, where a healthcare provider observes the characteristic ring-like skin lesions. Confirmatory tests may include skin scrapings examined microscopically with potassium hydroxide (KOH) preparation to identify fungal elements. In some cases, fungal cultures are performed to determine the specific dermatophyte involved. Differential diagnosis may include other dermatological conditions with similar presentations, making professional evaluation crucial.
Treatment Protocols: Treatment strategies for tinea imbricata usually involve antifungal medications, both topical and systemic, depending on the severity of the infection. Common approaches include: - Application of topical antifungal agents such as tolnaftate, ketoconazole, or clotrimazole to affected areas - In more extensive or resistant cases, oral antifungal medications like griseofulvin or terbinafine may be prescribed - Ensuring good personal hygiene, including keeping the skin dry and clean - Avoiding sharing personal items with infected individuals - Continuous monitoring for recurrence and maintaining skin health Since tinea imbricata can be persistent and recurrent, long-term follow-up with a healthcare professional is advisable to prevent reinfection. Education on hygiene practices and environmental factors can also be beneficial in managing the condition.
Clinical Advice & FAQs
Billing Guidance
Is B35.5 a billable ICD-10 code?
Yes, B35.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B35.5?
Clinical documentation must specify the nature of Tinea imbricata and any associated comorbidities for accurate reporting.
Cite this Clinical Reference